In a groundbreaking collaboration, Rymedi and Precision Genetics, both trailblazers in healthcare technology, have announced a strategic partnership. Their shared vision? To revolutionize health outcomes and operational efficiency through precision…
May 2, 2024 / Rymedi and Precision Genetics, two leading pioneers in healthcare technology solutions, proudly announce their strategic partnership aimed at transforming health outcomes and efficiencies through precision medicine.…
Rymedi is proud to announce its newest collaboration with BioSpy, the creators of Prostate IQ®, a next generation prostate cancer screening test. This new partnership will ensure the highest efficiency and security of…
Rymedi is proud to announce that CEO David Stefanich has been appointed to the Advisory Board at High Point University Phillips School of Business . His healthcare expertise will be useful in their launch…
Rymedi was honored with the 2024 S.C. Life Sciences Pinnacle Award for Organizational Contribution by SCbio during its annualconference in Greenville on February 8, 2024. SCbio gathered hundreds of life…
Rymedi has completed a Series A totaling $9 million with plans to expand the reach of our platform. The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s…
In a strategic alignment that champions the fusion of technology and healthcare, Zeeve-the prominent blockchain infrastructure-as-a-service platform played a pivotal role in supporting RYMEDI, a rising healthcare tech star from…
The list of South Carolina’s 50 Fastest Growing Companies has been announced, recognizing the achievements of South Carolina-headquarteredcompanies that have contributed to the Palmetto State’s economy through exceptional increases in…
